2018 Annual Meeting

Pre-Conference


CIS, along with AMLI, will once again be offering the Update on Diagnostic Advances in Primary Immunodeficiencies on Thursday, April 26, prior to the start of the 2018 Annual Meeting. This pre-conference will provide an intellectual forum for attendees to discuss the latest in diagnostic advances in the field if immune regulation and dysregulation.
 

View Program


 

Annual Meeting Program

The Annual Meeting and Update in PID pre-conference will provide a venue for the presentation of the newest immune deficiency diseases and the pathogenesis of these defects in molecular terms. The substance of the conference will be cutting edge clinical and basic science research. You can view the current draft program below.

Open AllClose All
  Thursday, April 26

7:00 am – 2:00pm
Update on Diagnostic Advances in Primary Immunodeficiencies Pre-Conference
(Separate Registration Required)
 

2:30pm – 2:40pm
Welcome from CIS President

Roshini Abraham, PhD

Mayo Clinic

 

2:40pm - 4:00pm
CIS Fellowship Grantee Presentations

1.5 AMA PRA Category 1 Credits™

 

Moderator:
Roshini Abraham, PhD
Mayo Clinic
 

Speaker:
Caroline Kuo, MD
University of California, Los Angeles

 

4:00pm - 6:00pm
Plenary Session: Patient Management: Controversies in PIDs

2 AMA PRA Category 1 Credits™


Moderators:
Steve Holland, MD
National Institute of Allergy and Infectious Disease, NIH
Troy Torgerson, MD, PhD
University of Washington & Seattle Children's Research Institute

Panelists:
Jack Routes, MD
Medical College of Wisconsin

Maite de la Morena, MD
University of Texas Southwestern

Alexandra Freeman, MD
National Institute of Health

Donald Vinh, MD
McGill University Health Centre

Klaus Warnatz, MD
Medical Center, University of Freiburg

Elie Haddad, MD, PhD
CHU Ste-Justine, University of Montreal

Lisa Forbes, MD
Baylor College of Medicine

 

6:00pm - 7:00pm
Robert A. Good Lecture

1 AMA PRA Category 1 Credits™

Speaker:
Akiko Shimamura, MD, PhD
Dana Farber/Boston Children's Cancer and Blood Disorders Center

  Friday, April 27

7:00 am - 8:00 am: Breakfast

7:00 am - 8:00 am
Genomics 101 A
*Separate Registration Required*

  • Isabelle Meyts, MD, Leuven University, Belgium
  • Asbjorg Stray-Pedersen, MD, PhD, Oslo University Hospital, Norway
     

7:00 am - 8:00 am
Genomics 101 B
*Separate Registration Required*

  • Ivan Chinn, MD, Baylor College of Medicine
  • Janet Chou, MD, Children’s Hospitalof Boston


8:00am - 9:30am
Plenary Session: Cross-Talk: PIDs from the Perspective of Other Specialties

1.5 AMA PRA Category 1 Credits™

Moderators:

Speakers:
TBD
Aleixo Muise, MD, PhD
Sick Kids Toronto

Tumor Predisposition in PID and Vice Versa
Markus Seidel, MD
Medical University Graz

TBD
Susanne Benseler, MD
Alberta Children’s Hospital, Calgary

TBD
Markus Boos, MD, PhD
Seattle Children’s Hospital

9:30am - 9:45am: Morning Break

9:45am - 11:30am
Plenary Session: The Thymus: Understanding the Biology, Diseases, and Treatment

2 AMA PRA Category 1 Credits™

Speakers:
TBD
Juan Carlos Zúñiga-Pflücker, PhD
Sunnybrook Research Institute, Canada

TBD
Graham Anderson, PhD
University of Birmingham, UK

TBD
Mary Louise Markert, MD, PhD
Duke University School of Medicine

11:30am - 1:00pm
Lunch/Exhibit Hall/Poster Hall Open

12:00 pm - 12:20 pm     
Lightning Poster Presentations

12:20 pm - 1:00 pm     
Poster Viewing


1:00 pm - 1:30 pm     
CIS Business Meeting


1:30pm - 3:00pm
Plenary Session: Immune Complications Caused by Therapeutic Intervention

1.5 AMA PRA Category 1 Credits™

Speakers:

Immune Dysregulation Following the Use of Checkpoint Inhibitors for Malignancies
Maria Suarez-Almazor, MD, PhD
MD Anderson Cancer Center

Immune Defects and Complications Following CAR-T Cell Therapies
Kevin Curran, MD
Memorial Sloan Kettering Cancer Center

Fontan and T Cell Lymphopenia
Jen Heimall, MD
Children's Hospital of Philadelphia
University of Cambridge, UK

3:00pm - 3:15pm: Afternoon Break

3:15pm - 4:15pm
Plenary Session: Registries

1 AMA PRA Category 1 Credits™
*Sponsored by USIDNET*


Moderators:
Kathleen Sullivan, MD, PhD
Children's Hospital of Philadelphia
Charlotte Cunningham-Rundles, MD, PHD
Mt. Sinai Medical Center

Speaker:
TBD
Nizar Mahlaoui, MD, MSc, MPH
French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Enfants Malades Hospital, University Paris Descartes, France

4:15pm - 4:30pm: Break

4:30pm - 5:30pm
Plenary Session:
CIS Rose/Fahey Founders Lecture

1 AMA PRA Category 1 Credits™

Speaker:
TBD
Megan Sykes, MD, PhD
Columbia Center for Translational Immunology

5:30pm - 6:00pm
Plenary Session:
PID Year in Review

  Saturday, April 28

7:00 am - 8:00 am: Breakfast

7:00 am - 8:00 am
Flow 101 A
*Separate Registration Required*

  • Troy Torgerson, MD, PhD, University of Washington
  • David Hagin, MD, Tel-Aviv Sourasky Medical Center, Israel


7:00 am - 8:00 am
Flow 101 B *Separate Registration Required*

  • Michael Keeney, London Health Sciences Center (Ontario)
  • James Verbsky, MD, PhD, Medical College of Wisconsin


8:00 am - 9:50 am    
Plenary Session: Novel Insights and Approaches to Regulating Immunity

2 AMA PRA Category 1 Credits™

Speakers:
New Treatments for Interferonopathies
Yanick Crow, BMedSci, MBBS, MRCP, PhD
University of Manchester, UK

Tregs Isolated From Thymus as a Potential Cell Therapy
Megan Levings, PhD
BC Children's Hospital Research Institute, Canada

New Insights in Treg Biology That Impact Human Disease
Ciriaco A. Piccirillo, MD
McGill University, Canada

Eculizumab for Early-Onset IBD in CD55 Deficiency
Kaan Boztug, MD
University of Vienna

Ustekinumab in Treating Complications of LAD
Steve Holland, MD
National Institute of Allergy and Infectious Disease, NIH

9:50 am - 10:00 am: Morning Break

10:00 am - 11:30 am     
Plenary Session: Transplantation: From Bone Marrow to Solid Organ

1.5 AMA PRA Category 1 Credits™

PIDTC Year in Review

  • Elie Haddad, MD, PhD
    CHU Ste-Justine, University of Montreal
  • Elizabeth Kang, MD
    National Institute of Allergy and Infectious Disease, NIH
  • Morton Cowan, MD
    UCSF Benioff Children's Hospital

SOT/HCT Combined Transplantation
Paul Szabolcs, MD
Children's Hospital of Pittsburgh

11:40 am -12:00 pm     
Plenary: Patient Advocacy Groups Update

.5 AMA PRA Category 1 Credits™

12:00 am - 2:00 pm     
Lunch/Exhibit Hall Open

1:00 pm - 1:20 pm     
Lightning Poster Presentations

1:20 pm - 2:00 pm     
Poster Viewing

2:00 pm - 3:30 pm     
Plenary: Tales from the Listserv

1.5 AMA PRA Category 1 Credits™

Moderators:

  • Eric Allenspach, MD, PhD
    University of Washington & Seattle Children's Hospital
  • Elie Haddad, MD, PhD
    CHU Ste-Justine, University of Montreal
  • Mikko Seppänen, MD, PhD
    Helsinki University Central Hospital


3:30 pm - 4:00 pm: Afternoon Break

4:00 pm - 5:00 pm     

Plenary: Richard Schiff Lecture
1 AMA PRA Category 1 Credits™
*Sponsored by Shire*

Speaker:
TBD
Bruce Blazar, MD
University of Minnesota

5:00 pm - 5:30pm     
Presidential Award Lecture
.5 AMA PRA Category 1 Credits™

Speaker:
TBD
Luigi Notarangelo, MD
NIH

5:30 pm - 7:00 pm     
Closing Reception in Exhibit Hall


7:00 pm - 9:00pm     
Dinner Symposium

Sponsored by CSL Behring
Topic: HAE: Clinical Aspects, Molecular Mechanisms and Treatment

  Sunday, April 29

7:00 am - 8:00 am: Breakfast

8:00 am - 10:30 am    
Plenary Session: Hot New Defects in Primary Immunodeficiencies

2.5 AMA PRA Category 1 Credits™

Speakers:
New Autoinflammatory Defects
Ivona Aksentijevich, MD
National Institutes of Health

TBD
Helka Goos, MD
University of Helsinki

TLR7 Deficiency
Eric Meffre, PhD
Yale University


Abstracts

Abstract submission is now closed

  • Abstracts submissions are collected through the online submission page only; e-mailed abstracts or any other form of submission will not be accepted.
  • There is no word/character limit to submissions. However, we encourage you to be as brief as possible when submitting.
  • Submitters are able to upload graphs and/or charts through the submission system.
  • Notification of selected Abstracts will take place in mid-to-late January.

 

Topics of Interest

The following is a list of categories of interest to CIS for abstract submission. This is not an inclusive list and abstracts on categories not listed will also be accepted.

  •     B cell biology
  •     Biological mechanisms of PID
  •     Hematopoietic cell transplantation and gene therapy
  •     Immune dysregulation in PID
  •     Immune modulating therapies
  •     Immunoglobulin replacement therapy
  •     Infections in PIDs
  •     Innate immunity
  •     NK cell biology
  •     Novel genetic etiologies of PIDs
  •     Phenotypic and molecular spectrum of Primary Immune Deficiency
  •     PID registries
  •     T cell biology

Registration Fees


On-site registration will be available if you are unable to register online anytime before March 30, 2018.

 

Pre-Conference Early Registration
(Until February 9)
Advance Registration
(Feb. 9 - March 30)
Update on PID Only $250 $300
Update on PID Discount with Annual Meeting $200 $250
Annual Meeting Early Registration
(Until February 9)
Advance Registration
(Feb. 9 - March 30)
CIS Regular Member $450 $550
CIS Trainee Member $200 $250
CIS Associate / Allied Health Member $200 $250
Non-Member $650 $750
Non-Member: Trainee $250 $300
Non-Member: Allied Health $300 $400
Industry / Sponsor / Exhibitor $350 $350
Developing Country (Member or Non-Member) $200 $250
One Day Registration (Member or Non-Member) $250 $300

Register Now

Register for the 2018 CIS Annual Meeting to ensure your spot at the preeminent North American conference dedicated to immune deficiency and dysregulation. The 2018 Annual Meeting will feature the latest in clinical and basic science research. This is your chance to hear and learn from experts from around the globe speak on the latest in immune deficiency and dysregulation.

 

Get Started

Hotel Information

The CIS 2018 Annual Meeting will be held at Sheraton Centre Toronto in Toronto, Ontario, Canada.

Sheraton Centre Toronto
123 Queen Street West
Toronto, ON, M5H 2M9, Canada
Ph: 416.361.1000

Attendees of the CIS 2018 Annual Meeting can reserve a room under the CIS block for CAD $249/night ($199 USD) (single/double occupancy), excluding taxes.

The deadline for reservations at this discounted rate is March 23, 2018

About the Sheraton Centre Toronto
Located in the heart of Downtown Toronto, the Sheraton Centre is close to the city's top attractions, including the Hockey Hall of Fame, the CN Tower, Casa Loma and the Royal Ontario Museum, as well as providing attendees with access to world class shopping, dining and entertainment. We look forward to seeing you in Toronto!
 

Book Your Hotel

Canada Travel Information

ALL VISITORS

To visit Canada, all travelers will need to meet some basic requirements:

  • Have a valid travel document, like a passport
  • Be in good health
  • Have no criminal or immigration-related convictions
  • Be able to explain to an immigration officer that you have ties—such as a job, home, financial assets or family—that will take you back to your home country
  • Explain to an immigration officer that you will leave Canada at the end of your visit
  • Have enough money for your stay (The amount of money you will need depends on how long you will stay and if you will stay in a hotel, or with friends or relatives).

ENTERING FROM THE UNITED STATES
  • The Canada Border Services Agency (CBSA) recommends that all US citizens carry a valid passport. A passport may be required by your airline or transportation authority.
  • If you are a United States citizen, be sure to carry proof of citizenship, such as a passport, along with photo identification. If you are a permanent U.S. resident, carry proof of your status such as a U.S. Permanent Resident Card.

ENTERING FROM NON-US COUNTRIES
  • All non-US visitors to Canada will be required to obtain either an Electronic Travel Authorization (eTA) or a visa for the length of their stay. Click below to determine which travel document you will
     

Do You Need an eTA or a Visitor Visa?
 

Exhibitors and Sponsors

Dear Colleagues,

On behalf of the Clinical Immunology Society (CIS), we invite you to participate in the 2018 Annual Meeting: Immune Deficiency & Dysregulation North American Conference taking place April 26-29, 2018 at the Sheraton Centre Toronto in Toronto, Ontario, Canada.

CIS is the key inter-disciplinary organization for the field of clinical immunology and is devoted to fostering developments in the science and practice of clinical immunology. The mission of CIS is to facilitate education, translational research and novel approaches to therapy in clinical immunology and to promote excellence in the care of patients with immunological and immune dysregulatory disorders.

Your participation is essential to the success of the Annual Meeting. Please take this opportunity to meet hundreds of healthcare professionals and educate them about your products and services. Join us for this momentous occasion that promises to be one of thebest conferences on primary immunodeficiency. We look forward to seeing you in Toronto!

Regards,

Roshini Abraham, PhD
Mayo Clinic
2018 Program Committee Co-Chair

Troy Torgerson, MD, PhD
University of Washington
2018 Program Committee Co-Chair

Oral Presentation Information

All speakers can access the speaker login site here. If you need your login credentials resent to you, please contact Sarah Tulley, CIS Meetings Manager, stulley@clinimmsoc.org.

Important Dates

February 9, 2018

Early Bird Registration Closes

 

March 23, 2018

Housing Closes

 

March 30, 2018

Online Registration Closes
*On-site registration will be available*

top